A Gratwohl|E Signer - JoVE Visualize

Showing results (91-100 of 404) with videos related to

Pageof 41

Sort By:

Schweizerische Medizinische Wochenschrift|November 9, 1996

[Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia]M J Bargetzi, A Tichelli, A Gratwohl, et al.

Gene|May 29, 1998

The chicken CP49 gene contains an extra exon compared to the human CP49 gene which identifies an important step in the evolution of the eye lens intermediate filament proteinsP Wallace, E Signer, I R Paton, et al.

Helvetica Paediatrica Acta|February 1, 1979

Antibodies to gliadin as a screening test for coeliac disease. A prospective studyE Signer, A Bürgin-Wolff, R Berger, et al.

Journal of Internal Medicine|April 1, 1993

Bone marrow transplantation in Europe: major geographical differences. The European Group for Bone Marrow Transplantation [EBMT]A Gratwohl, J Hermans, J M Goldman, et al.

Bone Marrow Transplantation|December 12, 2002

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity surveyA Gratwohl, H Baldomero, J Passweg, et al.

Bone Marrow Transplantation|June 8, 2006

EBMT activity survey 2004 and changes in disease indication over the past 15 yearsA Gratwohl, H Baldomero, K Frauendorfer, et al.

Clinical and Experimental Immunology|December 1, 1984

Functional and morphological suppressor T cell deficit in acute GVHDF Di Padova, A Gratwohl, M Corneo, et al.

Lancet (London, England)|June 7, 2002

Cerebral oedema as a possible complication of treatment with imatinibM Ebnöether, J Stentoft, J Ford, et al.

Schweizerische Medizinische Wochenschrift|March 9, 1991

[Tendency to thrombosis following bone marrow transplantation?]D A Tsakiris, B Huser, A Gratwohl, et al.

British Journal of Haematology|November 1, 1985

Stimulatory serum factors in aplastic anaemia. II. Prognostic significance for patients treated with high dose immunosuppressionC Nissen, Y Moser, B Speck, et al.

Pageof 41

Showing results (91-100 of 404) with videos related to

Sort By:

Pageof 41

Schweizerische Medizinische Wochenschrift|November 9, 1996

[Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia]M J Bargetzi, A Tichelli, A Gratwohl, et al.

Gene|May 29, 1998

The chicken CP49 gene contains an extra exon compared to the human CP49 gene which identifies an important step in the evolution of the eye lens intermediate filament proteinsP Wallace, E Signer, I R Paton, et al.

Helvetica Paediatrica Acta|February 1, 1979

Antibodies to gliadin as a screening test for coeliac disease. A prospective studyE Signer, A Bürgin-Wolff, R Berger, et al.

Journal of Internal Medicine|April 1, 1993

Bone marrow transplantation in Europe: major geographical differences. The European Group for Bone Marrow Transplantation [EBMT]A Gratwohl, J Hermans, J M Goldman, et al.

Bone Marrow Transplantation|December 12, 2002

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity surveyA Gratwohl, H Baldomero, J Passweg, et al.

Bone Marrow Transplantation|June 8, 2006

EBMT activity survey 2004 and changes in disease indication over the past 15 yearsA Gratwohl, H Baldomero, K Frauendorfer, et al.

Clinical and Experimental Immunology|December 1, 1984

Functional and morphological suppressor T cell deficit in acute GVHDF Di Padova, A Gratwohl, M Corneo, et al.

Lancet (London, England)|June 7, 2002

Cerebral oedema as a possible complication of treatment with imatinibM Ebnöether, J Stentoft, J Ford, et al.

Schweizerische Medizinische Wochenschrift|March 9, 1991

[Tendency to thrombosis following bone marrow transplantation?]D A Tsakiris, B Huser, A Gratwohl, et al.

British Journal of Haematology|November 1, 1985

Stimulatory serum factors in aplastic anaemia. II. Prognostic significance for patients treated with high dose immunosuppressionC Nissen, Y Moser, B Speck, et al.

Pageof 41